NeuroSense Therapeutics Ltd
NRSN - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$1.83M
Close$
$-0.00
100.2% downside
Current Fair Value
100.2% downsideOvervalued by 100.2% based on the discounted cash flow analysis.
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $1.83 Million |
|---|---|
| Enterprise Value | $1.83 Million |
| Earnings per Share | $-8.8 |
| Beta | 1.64 |
| Outstanding Shares | 1,278,000 |
Return
| Return on Equity | 713.14% |
|---|---|
| Return on Assets | -1082.20% |
| Return on Invested Capital | 744.96% |
Valuation & Multiples
| P/E Ratio | -0.28 |
|---|---|
| PEG | -0.36 |
| Price to Sales | - |
| Price to Book Ratio | -0.72 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | -0.17 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 0.09 |
| Debt to Equity | -0.11 |
Revenue Sources
No data
Last Earnings Call
Report Date
September 25, 2026
EPS Estimate
$-3.90
Consensus analyst estimateRevenue Estimate
$535,600
Consensus analyst estimateNext Earnings Call
Expected Date
December 2, 2026
EPS Estimate
$-0.79
Consensus analyst estimateRevenue Estimate
$535,600
Consensus analyst estimateInstitutional Put/Call Ratio
Compares institutional put options with call options. At 0.00, the ratio is below 1, so institutions hold more calls than puts.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 1.56%▲ 0.07% |
|---|---|
| Total Invested | $285,749▼ 0.32% |
| Investors Holding | 12▼ 1.00% |